Siegfried Holding AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SGFEF research report →
About the company
Siegfried Holding AG is a global enterprise active in the life sciences industry. The company is dedicated to developing and manufacturing active pharmaceutical ingredients (APIs) and their intermediate compounds, as well as a diverse range of finished drug products. These include solid oral medications, sterile and aseptically filled injectable solutions, ophthalmic preparations, and inhalable treatments.
- CEO
- Marcel Imwinkelried
- IPO
- 2014
- Employees
- 3,886
- HQ
- Zofingen, CH
Price Chart
- Market Cap
- $3.69B
- P/E
- 18.65
- P/S
- 2.37
- P/B
- 2.78
- EV/EBITDA
- 11.93
- Div Yield
- 0.56%
- Gross Margin
- 26.66%
- Op Margin
- 15.74%
- Net Margin
- 12.70%
- ROE
- 15.68%
- ROIC
- 9.22%
- Revenue
- $1.33B · 2.62%
- Net Income
- $168.74M · 5.42%
- EPS
- $3.85 · 3.77%
- Op Income
- $210.43M
- FCF YoY
- 182.67%
- 52W High
- $1001.00
- 52W Low
- $84.12
- 50D MA
- $95.87
- 200D MA
- $101.95
- Beta
- 0.79
- Avg Volume
- 26
Get TickerSpark's AI analysis on SGFEF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SGFEF coverage
Recent articles, reports, and earnings notes.
No research on SGFEF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SGFEF report →Similar companies
Peers in the same neighborhood.